- Home
- IPSC vs ONMD Comparison
IPSC vs ONMD Comparison
Compare IPSC & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- ONMD
- Stock Information
- Founded
- IPSC 2019
- ONMD 2006
- Country
- IPSC United States
- ONMD United States
- Employees
- IPSC N/A
- ONMD N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- ONMD
- Sector
- IPSC Health Care
- ONMD
- Exchange
- IPSC Nasdaq
- ONMD Nasdaq
- Market Cap
- IPSC 43.2M
- ONMD 43.5M
- IPO Year
- IPSC 2021
- ONMD N/A
- Fundamental
- Price
- IPSC $0.56
- ONMD $2.56
- Analyst Decision
- IPSC Strong Buy
- ONMD
- Analyst Count
- IPSC 5
- ONMD 0
- Target Price
- IPSC $3.33
- ONMD N/A
- AVG Volume (30 Days)
- IPSC 486.6K
- ONMD 15.0M
- Earning Date
- IPSC 11-04-2025
- ONMD 08-13-2025
- Dividend Yield
- IPSC N/A
- ONMD N/A
- EPS Growth
- IPSC N/A
- ONMD N/A
- EPS
- IPSC N/A
- ONMD N/A
- Revenue
- IPSC $114,128,000.00
- ONMD $459,000.00
- Revenue This Year
- IPSC $1,589.94
- ONMD N/A
- Revenue Next Year
- IPSC N/A
- ONMD N/A
- P/E Ratio
- IPSC N/A
- ONMD N/A
- Revenue Growth
- IPSC 5491.77
- ONMD N/A
- 52 Week Low
- IPSC $0.34
- ONMD $0.30
- 52 Week High
- IPSC $1.83
- ONMD $3.67
- Technical
- Relative Strength Index (RSI)
- IPSC 60.86
- ONMD 92.37
- Support Level
- IPSC $0.48
- ONMD $0.92
- Resistance Level
- IPSC $0.51
- ONMD $3.67
- Average True Range (ATR)
- IPSC 0.03
- ONMD 0.27
- MACD
- IPSC 0.01
- ONMD 0.15
- Stochastic Oscillator
- IPSC 67.79
- ONMD 60.35
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.